Tofenacin hydrochloride

This classification denotes an anticholinergic agent with the molecular structure C17H21NO.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 3A10ND4DWR chemically known as ethanamine, n-methyl-2-((2-methylphenyl)phenylmethoxy)-, hydrochloride, but more commonly known as tofenacin hydrochloride, which bears US NIH Compound Identifier 25314. European Medicines Agency schedules Tofenacin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04904MIG. Most nations, for tariff and trade purposes, schedule tofenacin hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, TOFENACIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Tofenacin hydrochloride bears US NLM identifiers UMLS ID C2825640 and NCI Concept Code C81452. SMILES: CC1CCCCC1C(C2CCCCC2)OCCNC.CL.